Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000904454-05-000094
Filing Date
2005-02-03
Accepted
2005-02-03 15:44:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 CRITICAL THERAPEUTICS INC. SCHEDULE 13G s13g_0202-2005cti.txt SC 13G 11776
  Complete submission text file 0000904454-05-000094.txt   13103
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Filed by) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 0103
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 675 MASSACHUSETTS AVE 14TH FLOOR CAMBRIDGE MA 02139 6173549311
CRITICAL THERAPEUTICS INC (Subject) CIK: 0001145404 (see all company filings)

EIN.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-79887 | Film No.: 05573268
SIC: 2834 Pharmaceutical Preparations